Immudex is actively monitoring COVID-19 developments. While we are committed to keep supporting our customers' research in this challenging time caused by COVID-19 pandemic, we ensure that all our employees work in a safe environment, respecting the guidelines proposed by the Danish health authorities.
Get Immudex' latest news and promotions.
Recent literature has shown that T-cell responses to SARS-CoV-2 are crucial for the recovery of COVID-19 disease.
Understanding the specificity, frequency, and durability of the T-cell response is important for defining correlates of protective immunity and helping researchers identify effective vaccine antigens.
We want to share with you a curated list of the published epitopes shown to be recognized by T cells in COVID-19 patients. Thanks to it, you can now choose the most suitable epitopes for your SARS-CoV-2 specific T-cells research.
Download the Immudex COVID-19 epitope list and see how the Dextramer® and dCODE® Technologies can help you unravel the specificity of COVID-19 T-cell immunity with high specificity and sensitivity.
Solutions for improved T-cell immune monitoring within immuno-oncology, transplantation, autoimmunity and infectious disease.
Detect antigen-specific CD8+ and CD4+ T cells with high sensitivity, without missing low-affinity T cells.
Simultaneous high-throughput analysis of multiple antigen-specific T cell populations in the same sample.
Multimerize your molecule onto Klickmer and realize a high-valence detection reagent.